[ad_1]
The vaccine from the University of Oxford and AstraZeneca was approved this Wednesday by the competent British authority (MHRAgovuk). The UK has ordered 100 million doses from the pharmaceutical company AstraZeneca, enough to vaccinate 50 million people across the country.
Welcoming the approval, Health Minister Matt Hancock announced that the vaccine would be available next Monday, January 4.
“It’s great that we end 2020 with a moment of hope: The Oxford / AstraZeneca coronavirus vaccine was approved today for use by @mhragovuk. The coronavirus vaccine is our way out of the pandemic – now we have to maintain the calm while “We are overcoming it (the health crisis) together,” commented Mr. Hancock.
Brilliantly ending 2020 with a moment of hope: the @UniofOxford / @AstraZeneca #coronavirus The vaccine has been licensed today for use by @mhragovuk
the #coronavirus The vaccine is our way out of the pandemic; now we have to keep our nerves as we get through this together.
– Matt Hancock (@MattHancock) December 30, 2020
The Oxford-AstraZeneca vaccine was designed in the first months of 2020, tested with the first volunteer in April, and has since undergone large-scale clinical trials involving thousands of people.
“It marks a major turning point and will lead to a massive expansion of the UK immunization campaign, which aims to bring life back to normal,” the BBC said.
At the same time, it is unlikely that the European Medicines Agency (EMA) will be able to approve the AstraZeneca vaccine and the University of Oxford in January. “They haven’t even asked us yet,” Noel Wathion, executive director of the European Regulatory Authority, told Belgian newspaper Het Nieuwsblad on Tuesday.
Source: skai.gr
[ad_2]
